Clinical Trials
7 trialsNCT05735717 2026-04-06
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT07485855 2026-03-24
(HEM-FLU)
Asan Medical Center
Phase 3 Recruiting
NCT04712539 2026-02-11
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT01924169 2018-09-20
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01215981 2017-12-28
Influenza Vaccine Post Allogeneic Transplant
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT00962715 2012-08-03
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT01016548 2010-06-04
Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
University Health Network, Toronto
Phase 3 Completed